Protalix BioTherapeutics, Inc. (AMEX:PLX) Q4 2023 Earnings Call Transcript

Protalix BioTherapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.07 EPS, expectations were $-0.03. Protalix BioTherapeutics, Inc.

Keep Reading →